We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

168 hedge funds and large institutions have $2.04B invested in Medicines Co in 2013 Q2 according to their latest regulatory filings, with 168 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $15.4M

Holders
168
Holders Change
+168
Holders Change %
–
% of All Funds
5.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
168
Increased
–
Reduced
–
Closed
–
Calls
$23.6M
Puts
$15.4M
Net Calls
+$8.18M
Net Calls Change
+$8.18M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SAC
1
Smith Affiliated Capital
New York
$284M – – –
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$177M +$192M +5,752,095 New
Wellington Management Group
3
Wellington Management Group
Massachusetts
$176M +$192M +5,725,145 New
RA
4
Royce & Associates
New York
$125M +$136M +4,052,665 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$112M +$122M +3,655,514 New
BFA
6
BlackRock Fund Advisors
California
$103M +$112M +3,358,242 New
BIT
7
BlackRock Institutional Trust
California
$58.7M +$63.9M +1,909,315 New
HM
8
HealthCor Management
New York
$51.5M +$56M +1,675,000 New
State Street
9
State Street
Massachusetts
$51.1M +$55.6M +1,662,588 New
PC
10
PointState Capital
New York
$51.1M +$55.6M +1,660,800 New
BM
11
Bridger Management
New York
$43.4M +$47.2M +1,410,000 New
Lord, Abbett & Co
12
Lord, Abbett & Co
New Jersey
$42.9M +$46.7M +1,395,996 New
Invesco
13
Invesco
Georgia
$42.2M +$45.9M +1,370,664 New
JP Morgan Chase
14
JP Morgan Chase
New York
$35M +$38M +1,136,479 New
Jennison Associates
15
Jennison Associates
New York
$32.6M +$35.4M +1,059,340 New
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$29.7M +$32.3M +966,338 New
Fidelity Investments
17
Fidelity Investments
Massachusetts
$27.6M +$30M +897,000 New
RIM
18
RS Investment Management
California
$27.3M +$29.7M +887,784 New
Northern Trust
19
Northern Trust
Illinois
$27M +$29.4M +878,038 New
CCM
20
Consonance Capital Management
New York
$25.7M +$27.9M +834,798 New
BA
21
BlackRock Advisors
Delaware
$24.6M +$26.7M +798,165 New
CCI
22
Columbus Circle Investors
$24M +$26.1M +779,554 New
PA
23
Pinnacle Associates
New York
$22.1M +$24.1M +719,472 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$19.3M +$21M +628,718 New
O
25
OppenheimerFunds
New York
$18.1M +$19.7M +588,690 New
1
2 3 4 5

MDCO Hedge Fund Activity: Q2 2013 in Review

168 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q2 2013, worth a combined $2.04B.

Buyers outnumbered sellers: 168 funds opened new MDCO positions and 0 closed out — a net gain of 168 holders — while 0 added to existing stakes and 0 trimmed.

  • 168 institutional investors held Medicines Co (MDCO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.04B of Medicines Co stock for Q2 2013.
  • 168 funds opened new Medicines Co positions in Q2 2013 and 0 closed out, a net change of +168 holders.

Based on aggregated 13F filings for Q2 2013.